Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001;2002(1):CD001520.
doi: 10.1002/14651858.CD001520.

Melatonin for preventing and treating jet lag

A Herxheimer  1 , K J Petrie
Affiliations

Melatonin for preventing and treating jet lag

A Herxheimer et al. Cochrane Database Syst Rev. 2001.

Update in

Abstract

Background: Jet-lag commonly affects air travellers who cross several time zones. It results from the body's internal rhythms being out of step with the day-night cycle at the destination. Melatonin is a pineal hormone that plays a central part in regulating bodily rhythms and has been used as a drug to re-align them with the outside world.

Objectives: To assess the effectiveness of oral melatonin taken in different dosage regimens for alleviating jet-lag after air travel across several time zones.

Search strategy: We searched the Cochrane Controlled Trials Register, MEDLINE, EMBASE, PsychLit and Science Citation Index electronically, and the journals 'Aviation, Space and Environmental Medicine' and 'Sleep' by hand. We searched citation lists of relevant studies for other relevant trials. We asked principal authors of relevant studies to tell us about unpublished trials. Reports of adverse events linked to melatonin use outside randomised trials were searched for systematically in 'Side Effects of Drugs' (SED) and SED Annuals, 'Reactions Weekly', MEDLINE, and the adverse drug reactions databases of the WHO Uppsala Monitoring Centre (UMC) and the US Food & Drug Administration.

Selection criteria: Randomised trials in airline passengers, airline staff or military personnel given oral melatonin, compared with placebo or other medication. Outcome measures should consist of subjective rating of jet-lag or related components, such as subjective wellbeing, daytime tiredness, onset and quality of sleep, psychological functioning, duration of return to normal, or indicators of circadian rhythms.

Data collection and analysis: : Ten trials met the inclusion criteria. All compared melatonin with placebo; one in addition compared it with a hypnotic, zolpidem. Nine of the trials were of adequate quality to contribute to the assessment, one had a design fault and could not be used in the assessment. Reports of adverse events outside trials were found through MEDLINE, 'Reactions Weekly', and in the WHO UMC database.

Main results: : Nine of the ten trials found that melatonin, taken close to the target bedtime at the destination (10pm to midnight), decreased jet-lag from flights crossing five or more time zones. Daily doses of melatonin between 0.5 and 5mg are similarly effective, except that people fall asleep faster and sleep better after 5mg than 0.5mg. Doses above 5mg appear to be no more effective. The relative ineffectiveness of 2mg slow-release melatonin suggests that a short-lived higher peak concentration of melatonin works better. Based on the review, the number needed to treat (NNT) is 2. The benefit is likely to be greater the more time zones are crossed, and less for westward flights. The timing of the melatonin dose is important: if it is taken at the wrong time, early in the day, it is liable to cause sleepiness and delay adaptation to local time. The incidence of other side effects is low. Case reports suggest that people with epilepsy, and patients taking warfarin may come to harm from melatonin.

Reviewer's conclusions: Melatonin is remarkably effective in preventing or reducing jet-lag, and occasional short-term use appears to be safe. It should be recommended to adult travellers flying across five or more time zones, particularly in an easterly direction, and especially if they have experienced jet-lag on previous journeys. Travellers crossing 2-4 time zones can also use it if need be. The pharmacology and toxicology of melatonin needs systematic study, and routine pharmaceutical quality control of melatonin products must be established. The effects of melatonin in people with epilepsy, and a possible interaction with warfarin, need investigation.

PubMed Disclaimer

Conflict of interest statement

None [AH]; Keith Petrie has undertaken two of the trials reviewed.

Figures

1.1
1.1. Analysis
Comparison 1 Melatonin versus placebo: Eastward flights, Outcome 1 Global jet‐lag ratings.
2.2
2.2. Analysis
Comparison 2 Melatonin versus placebo: Westward flights, Outcome 2 Global jet lag ratings: Westward flights.
3.1
3.1. Analysis
Comparison 3 Melatonin versus placebo: Eastward flights, Outcome 1 Proportion of people with jet lag score >60.
See this image and copyright information in PMC

References

References to studies included in this review

Arendt 1987 {published data only}
    1. Arendt J, Aldhous M, English J, Marks V, Arendt JH, Marks M, Folkard S. Some effects of jet‐lag and their alleviation by melatonin. Ergonomics 1987;30:1379‐93.
    1. Arendt J, Aldhous M, Marks V. Alleviation of jet lag by melatonin: preliminary results of controlled double blind trial. BMJ 1986;292:1170. - PMC - PubMed
Arendt 1988 {published data only}
    1. Arendt J, Aldhous M. Further evaluation of the treatment of jet lag by melatonin: a double blind crossover study. Annual Review of Chronopharmacology 1988;5:53‐55.
    1. Skene DJ, Aldhous M, Arendt J. Melatonin, jet lag and sleep‐wake cycle.. Sleep '88. Proceedings of the 9th European Congress of Sleep Research, Jerusalem 1988. Stuttgart/New York: Gustav Fischer, 1989:39‐41.
Claustrat 1992 {published data only}
    1. Claustrat B, Brun J, David M, Sassolas G, Chazot G. Melatonin and jet lag: confirmatory result using a simplified protocol. Biological Psychiatry 1992;32:705‐11. - PubMed
Edwards 2000 {published data only}
    1. Edwards BJ, Atkinson G, Waterhouse J, Reilly T, Godfrey R, Budgett R. Use of melatonin in recovery from jet‐lag following an eastward flight across 10 time‐zones. Ergonomics 2000;43:1501‐13. - PubMed
Nickelsen 1991 {published data only}
    1. Nickelsen T, Lang A, Bergau L. The effect of 6‐, 9‐ and 11‐hour time shifts on circadian rhythms: adaptation of sleep parameters and hormonal patterns following the intake of melatonin or placebo. In: Arendt J, Pevet P editor(s). Advances in Pineal Research. Vol. 5, John Libbey & Co, 1991:303‐6.
Petrie 1989 {published data only}
    1. Petrie K, Conaglen JV, Thompson, Chamberlain K. Effect of melatonin on jet lag after long haul flights. BMJ 1989;298:705‐7. - PMC - PubMed
Petrie 1993 {published data only}
    1. Petrie K, Dawson AG, Thompson L, Brook R. A double‐blind trial of melatonin as a treatment for jet lag in international cabin crew. Biological Psychiatry 1993;33:526‐30. - PubMed
Spitzer 1997 {published data only}
    1. Spitzer RL, Terman M, Malt U, Singer F, Terman JS, Williams JB, et al. Failure of melatonin to affect jet lag in a randomized double blind trial. Society for Light Treatment and Biological Rhythms: SLTBR Abstracts 1997;9:1.
    1. Spitzer RL, Terman M, Williams JB, Terman JS, Malt UF, Singer F, et al. Jet lag: clinical features, validation of a new syndrome‐specific scale, and lack of response to melatonin in a randomized double‐blind trial. American Journal of Psychiatry 1999;156:1392‐6. - PubMed
Suhner 1998a {published data only}
    1. Suhner A, Schlagenhauf P, Johnson R, Tschopp A, Steffen R. Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag. Chronobiology International 1998b;15:655‐66. - PubMed
Suhner 1998b {published data only}
    1. Suhner A, Schlagenhauf P, Hoefer I, Johnson R, Tschopp A, Steffen R. Efficacy and tolerability of melatonin and zolpidem for the alleviation of jet‐lag. Book of Abstracts, 6th Conference of the International Society of Travel Medicine, Montreal, Canada, June 6‐10,1999. 1999:95, abs G03.
    1. Suhner A, Schlagenhauf P, Hoefer I, Johnson R, Tschopp A, Steffen R. Efficacy and tolerability of melatonin and zolpidem for the alleviation of jet‐lag.. Suhner A. Melatonin and jet‐lag. Dissertation ETH No. 12823. Zurich, Switzerland: Swiss Federal Institute of Technology, 1988:85‐103.

References to studies excluded from this review

Arendt 1995 {published data only}
    1. Arendt J, Deacon S. Treatment of circadian rhythm disorders. Chronobiology International 1997;14:185‐204. - PubMed
    1. Arendt J, Deacon S, English J, Hampton S, Morgan L. Melatonin and adjustment to phase shift. Journal of Sleep Research 1995;4 Suppl 2:74‐9. - PubMed
    1. Arendt J, Skene DJ, Middleton B, Lockley S, Deacon S. Efficacy of melatonin treatment in jet lag, shift work and blindness. Journal of Biological Rhythms 1997;12:604‐17. - PubMed
Comperatore 1996 {published data only}
    1. Comperatore CA, Lieberman HR, Kirby AW, Adams B, Crowley JS. Melatonin efficacy in aviation missions requiring rapid deployment and night operations. Aviation, Space and Environmental Medicine 1996;67:520‐4. - PubMed

Additional references

Armstrong 1986
    1. Armstrong SM, Cassone VM, Chesworth MJ, Redman JR, Short RV. Synchronization of mammalian circadian rhythms by melatonin. Journal of Neural Transmission. Supplementum 1986;21:375‐94. - PubMed
Bardazzi 1998
    1. Bardazzi F, Placucci F, Neri I, D'Antuono A, Patrizi A. Fixed drug eruption due to melatonin. Acta Dermato‐Venereologica 1998;78(1):69‐70. - PubMed
Cochrane 1999
    1. Cochrane Collaboration. Cochrane Reviewers' Handbook. Oxford: Update Software, 1999.
Comperatore 1990
    1. Comperatore CA, Krueger GP. Circadian rhythm desynchronosis, jet lag, shift lag and coping strategies. In: Scott I editor(s). Occupational Medicine: state of the art reviews. Vol. 5, Philadelphia, PY: Hanley& Belfus, 1990:323‐42. - PubMed
Dalton 2000
    1. Dalton EJ, Rotondi D, Levitan RD, Kennedy RH, Brown GM. Use of slow‐release melatonin in treatment‐resistant depression. Journal of Psychiatry and Neuroscience 2000;25(1):48‐52. - PMC - PubMed
Ellis 1996
    1. Ellis CM, Lemmens G, Parkes JD. Melatonin and insomnia. Journal of Sleep Research 1996;5(1):61‐5. - PubMed
Force 1997
    1. Force RW, Hansen L, Bedell M. Psychotic episode after melatonin. Annals of Pharmacotherapy 1997;31(11):1408. - PubMed
Lewy 1992
    1. Lewy AJ, Ahmed S, Jackson JM, Sack RI. Melatonin shifts human circadian rhythms according to phase response curve.. Chronobiology International 1992;9(5):380‐92. - PubMed
Lewy 1995
    1. Lewy AJ, Sack RL, Blood ML, Bauer VK, Cutler NL, Thomas KH. Melatonin marks circadian phase position and resets the endogenous circadian pacemaker in humans. Circadian clocks and their adjustment, Ciba Foundation Symposium 183. Chichester: Wiley, 1995:303‐21. - PubMed
Martindale 1999
    1. Martindale. The complete drug reference. 2nd Edition. London: Pharmaceutical Press, 1999.
Pennebaker 1982
    1. Pennebaker JW. The psychology of physical symptoms. New York, NY: Springer Verlag, 1982.
SED 1996
    1. Dukes MN. Meyler's Side Effects of Drugs. 13th Edition. Amsterdam: Elsevier, 1996.
SEDA 1999
    1. Aronson JK. Side Effects of Drugs Annual. Vol. 10‐23, Amsterdam: Elsevier, 1986 to 1999.
Sheldon 1998
    1. Sheldon SH. Pro‐convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998;351(9111):1254. - PubMed
Waterhouse 1997
    1. Waterhouse J, Reilly T, Atkinson G. Jet‐lag. Lancet 1997;350(9091):1611‐16. - PubMed
Winget 1984
    1. Winget CM, DeRoshia CW, Markley CL, Holley DC. A review of the human physiological changes associated with desynchronosis of biological rhythms. Aviation Space and Environmental Medicine 1984;55(12):1085‐96. - PubMed
Zhdanova 2000
    1. Zhdanova IV. The role of melatonin in sleep and sleep disorders. In: Culebras A editor(s). Sleep disorders and neurological disease. New York, NY ‐ Basel: Marcel Dekker, 2000:137‐57.

Publication types

MeSH terms